Suppr超能文献

Hereditary renal cell carcinoma associated with von Hippel-Lindau disease: a description of a Nova Scotia cohort.

作者信息

Bradley Shannon, Dumas Nadine, Ludman Mark, Wood Lori

机构信息

Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, the.

出版信息

Can Urol Assoc J. 2009 Feb;3(1):32-6. doi: 10.5489/cuaj.1013.

Abstract

BACKGROUND

von Hippel-Lindau (VHL) disease is an autosomal dominant condition characterized by the development of benign and malignant tumours, including cases of renal cell carcinoma (RCC). Early detection of RCC through routine surveillance can lead to decreased morbidity and mortality. Data on the number of patients in Nova Scotia (NS) who have VHL disease, disease manifestations and the frequency and mode of the surveillance have not previously been collected or reported. This project was designed to obtain that information.

METHODS

The number and management of patients with VHL disease was determined by multiple sources: the Maritime Medical Genetics Service, patient charts, and pathology, radiology and laboratory data. The actual surveillance being performed was compared with that recommended in the literature.

RESULTS

Twenty-one patients from 11 families in NS were identified. Manifestations included cases of RCC (31.6%), central nervous system (CNS) hemangioblastoma (73.7%), retinal hemangioma (47.4%), renal cyst (47.4%) and pheochromocytoma (10.5%). Of the 6 patients with RCC, 4 had bilateral tumours, 2 required kidney transplants and 1 developed metastatic disease. Routine surveillance was being done for the CNS in 62.5% of patients, retina in 47.4%, abdomen in 43.8% and urine catecholamines in only 10.5%. Only 1 of the 6 patients who developed RCC was undergoing routine abdominal imaging. Surveillance investigations were ordered by a number of different specialists.

CONCLUSION

Patients with VHL disease in NS have a number of manifestations associated with their disease, including RCC, in a similar frequency to that reported in the literature. The surveillance of these patients is suboptimal in frequency and coordination. von Hippel-Lindau disease is a complex condition that requires a coordinated approach to care to ensure proper surveillance and treatment. Our study highlights current deficiencies and offers an enormous opportunity for improvement.

摘要

相似文献

2
4
Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
Clin Genet. 2019 Nov;96(5):461-467. doi: 10.1111/cge.13613. Epub 2019 Aug 6.
5
Surveillance in von Hippel-Lindau disease (vHL).
Clin Genet. 2010 Jan;77(1):49-59. doi: 10.1111/j.1399-0004.2009.01281.x. Epub 2009 Oct 15.
8
Von Hippel-Lindau syndrome. A pleomorphic condition.
Cancer. 1999 Dec 1;86(11 Suppl):2478-82.
9
Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature.
Oncol Lett. 2015 Aug;10(2):1087-1090. doi: 10.3892/ol.2015.3279. Epub 2015 May 27.
10
Survival and causes of death in patients with von Hippel-Lindau disease.
J Med Genet. 2017 Jan;54(1):11-18. doi: 10.1136/jmedgenet-2016-104058. Epub 2016 Aug 18.

引用本文的文献

1
The Current State of the Diagnoses and Treatments for Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2024 Dec 1;16(23):4034. doi: 10.3390/cancers16234034.
2
Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack.
Endocr Connect. 2021 Oct 27;10(11):R293-R304. doi: 10.1530/EC-21-0294.
3
Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature.
Oncol Lett. 2015 Aug;10(2):1087-1090. doi: 10.3892/ol.2015.3279. Epub 2015 May 27.
5
Canadian guideline on genetic screening for hereditary renal cell cancers.
Can Urol Assoc J. 2013 Sep-Oct;7(9-10):319-23. doi: 10.5489/cuaj.1496.

本文引用的文献

1
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.
Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s. doi: 10.1158/1078-0432.CCR-06-1865.
2
Management of von Hippel-Lindau-associated kidney cancer.
Nat Clin Pract Urol. 2005 May;2(5):248-55. doi: 10.1038/ncpuro0179.
3
Role of VHL gene mutation in human cancer.
J Clin Oncol. 2004 Dec 15;22(24):4991-5004. doi: 10.1200/JCO.2004.05.061.
4
Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6282S-9S. doi: 10.1158/1078-0432.CCR-050013.
5
von Hippel-Lindau disease.
Lancet. 2003 Jun 14;361(9374):2059-67. doi: 10.1016/S0140-6736(03)13643-4.
6
VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma.
J Natl Cancer Inst. 2002 Oct 16;94(20):1569-75. doi: 10.1093/jnci/94.20.1569.
7
Von Hippel-Lindau disease: gene to bedside.
Curr Opin Neurol. 2001 Dec;14(6):695-703. doi: 10.1097/00019052-200112000-00004.
10
A rational approach to radiological screening in von Hippel-Lindau disease.
J Med Screen. 1994 Apr;1(2):88-95. doi: 10.1177/096914139400100205.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验